BACKGROUND AND OBJECTIVE: Programmed cell death-1 (PD-1) represents a mechanism of T-cell dysfunction in hepatitis B virus (HBV) persistence. In peripheral blood, PD-1 is up-regulated in virus-specific T cells, leading to the impairment of T cells. This study investigated the intrahepatic expression of PD-1 and its ligand (PD-L) in patients with chronic hepatitis B (CHB) virus. METHODS: Liver specimens were obtained from CHB (n = 56), acute hepatitis B (AHB, n = 12) patients and age-matched healthy subjects (n = 10). The expression of PD-1/PD-L was determined by immunohistochemistry. RESULTS: In CHB patients, PD-1 was predominantly expressed in lymphocytes infiltrating the portal tract. PD-L1 was detected in lymphocytes, hepatocytes and liver sinusoidal endothelial cells, while PD-L2 was localized in Kupffer cells and dendritic cells. The labeling indexes of PD-1 and PD-L1 in lymphocytes infiltrating portal area were significantly higher in CHB patients than in healthy controls and AHB patients. Within the CHB patients, the increases in labeling indexes of PD-1 and PD-L paralleled the degree of inflammation. CONCLUSIONS: These results suggest that over-expression of PD-1, PD-L1 and PD-L2 within liver may participate in local immune dysfunction, which could be one of the mechanisms involved in the chronicity of HBV infection and chronic inflammation seen in CHB patients.
BACKGROUND AND OBJECTIVE: Programmed cell death-1 (PD-1) represents a mechanism of T-cell dysfunction in hepatitis B virus (HBV) persistence. In peripheral blood, PD-1 is up-regulated in virus-specific T cells, leading to the impairment of T cells. This study investigated the intrahepatic expression of PD-1 and its ligand (PD-L) in patients with chronic hepatitis B (CHB) virus. METHODS: Liver specimens were obtained from CHB (n = 56), acute hepatitis B (AHB, n = 12) patients and age-matched healthy subjects (n = 10). The expression of PD-1/PD-L was determined by immunohistochemistry. RESULTS: In CHB patients, PD-1 was predominantly expressed in lymphocytes infiltrating the portal tract. PD-L1 was detected in lymphocytes, hepatocytes and liver sinusoidal endothelial cells, while PD-L2 was localized in Kupffer cells and dendritic cells. The labeling indexes of PD-1 and PD-L1 in lymphocytes infiltrating portal area were significantly higher in CHB patients than in healthy controls and AHB patients. Within the CHB patients, the increases in labeling indexes of PD-1 and PD-L paralleled the degree of inflammation. CONCLUSIONS: These results suggest that over-expression of PD-1, PD-L1 and PD-L2 within liver may participate in local immune dysfunction, which could be one of the mechanisms involved in the chronicity of HBV infection and chronic inflammation seen in CHB patients.
Authors: Spencer C Liang; Yvette E Latchman; Janet E Buhlmann; Michal F Tomczak; Bruce H Horwitz; Gordon J Freeman; Arlene H Sharpe Journal: Eur J Immunol Date: 2003-10 Impact factor: 5.532
Authors: Marcus Mühlbauer; Martin Fleck; Christian Schütz; Thomas Weiss; Matthias Froh; Christian Blank; Jürgen Schölmerich; Claus Hellerbrand Journal: J Hepatol Date: 2006-06-16 Impact factor: 25.083
Authors: Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker Journal: Nature Date: 2006-08-20 Impact factor: 49.962
Authors: Christine S Rollier; Glaucia Paranhos-Baccala; Ernst J Verschoor; Babs E Verstrepen; Joost A R Drexhage; Zahra Fagrouch; Jean-Luc Berland; Florence Komurian-Pradel; Blandine Duverger; Nourredine Himoudi; Caroline Staib; Marcus Meyr; Mike Whelan; Joseph A Whelan; Victoria C Adams; Victoria A Adams; Esther Larrea; José I Riezu; Juan J Lasarte; Juan José Lasarte; Birke Bartosch; Francois-L Cosset; Willy J M Spaan; Helmut M Diepolder; Gerd R Pape; Gerd Sutter; Genevieve Inchauspe; Jonathan L Heeney Journal: Hepatology Date: 2007-03 Impact factor: 17.425
Authors: Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed Journal: Nature Date: 2005-12-28 Impact factor: 49.962
Authors: Irina P Balmasova; Nikolay D Yushchuk; Ospan A Mynbaev; Nageswara R Alla; Elena S Malova; Zhongjie Shi; Chang-Lu Gao Journal: World J Gastroenterol Date: 2014-10-21 Impact factor: 5.742
Authors: Lauren A Licata; Cang T Nguyen; Rachel A Burga; Vincent Falanga; N Joseph Espat; Alfred Ayala; Mitchell Thorn; Richard P Junghans; Steven C Katz Journal: J Leukoc Biol Date: 2013-07-24 Impact factor: 4.962
Authors: Sariah J Allen; Pedram Hamrah; David Gate; Kevin R Mott; Dimosthenis Mantopoulos; Lixin Zheng; Terrence Town; Clinton Jones; Ulrich H von Andrian; Gordon J Freeman; Arlene H Sharpe; Lbachir BenMohamed; Rafi Ahmed; Steven L Wechsler; Homayon Ghiasi Journal: J Virol Date: 2011-02-09 Impact factor: 5.103